Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the  Terms of Use and  Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA's XBRL website for information about XBRL and the voluntary program.
Click here for information about XBRL software and viewing XBRL financial statements.

TD Global Biotechnology RSP Fund
Date of Formation:	Oct 2 2000	Auditor:	Deloitte & Touche LLP
Sales Compensation:	Option of Sales Charge or Redemption Charge	(Principal) Custodian:	The Toronto-Dominion Bank
Investment Fund Type:	Other	(Principal) Distributor:	TD Investment Services Inc.
Eligible for RRSP:	Yes	Investment Portfolio Manager:	TD Asset Management Inc.
Financial Year-End:	Dec 31	Trustee:	TD Asset Management Inc.
Reporting Jurisdictions:	Ceased Reporting

This fund is a previous issuer to   TD Health Sciences RSP Fund

Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the  Terms of Use and  Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA's XBRL website for information about XBRL and the voluntary program.
Click here for information about XBRL software and viewing XBRL financial statements.